SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001104659-21-071328
Filing Date
2021-05-24
Accepted
2021-05-24 17:14:57
Documents
4
Group Members
ALLEN GABRIELANTHONY CARACCIOLOANTONIO PARISIARLYN J. BOSSENBROOKARTHUR L. WILMESBRENDAN THORSONCHARLES M. JOHNSON JR.DR. RICHARD PESTELLFRANCESCO TOSCOFREDERICK J. AXELBERDGLENN EISENBERGJACK CHITAYATJEFFREY D. WEINERJEFFREY PAUL BEATYJOE RECTORJONATHAN

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D tm2117322d1_sc13d.htm SC 13D 734447
2 EXHIBIT 99.1 tm2117322d1_ex99-1.htm EX-99.1 44319
3 EXHIBIT 99.2 tm2117322d1_ex99-2.htm EX-99.2 44892
4 EXHIBIT 99.3 tm2117322d1_ex99-3.htm EX-99.3 20691
  Complete submission text file 0001104659-21-071328.txt   846482
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Subject) CIK: 0001175680 (see all company filings)

IRS No.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: SC 13D | Act: 34 | File No.: 005-79349 | Film No.: 21956065
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2945 NW LURAY TERRACE PORTLAND OR 97210
Business Address
Rosenbaum Paul (Filed by) CIK: 0001863643 (see all company filings)

Type: SC 13D